Clinical Cancer Research: 16 (11)

Highlights

Highlights

Highlights of This Issue

Clin Cancer Res June 1 2010 16 (11) 2919-2919;

CCR New Strategies

CCR New Strategies

New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer

Hans Prenen, Sabine Tejpar and Eric Van Cutsem

Clin Cancer Res June 1 2010 16 (11) 2921-2926; DOI:10.1158/1078-0432.CCR-09-2029

Molecular Pathways

Molecular Pathways

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

Beverly A. Teicher and Simon P. Fricker

Clin Cancer Res June 1 2010 16 (11) 2927-2931; DOI:10.1158/1078-0432.CCR-09-2329
Molecular Pathways

Control of Tumorigenesis and Chemoresistance by the DEK Oncogene

Erica Riveiro-Falkenbach and María S. Soengas

Clin Cancer Res June 1 2010 16 (11) 2932-2938; DOI:10.1158/1078-0432.CCR-09-2330

Human Cancer Biology

Human Cancer Biology

The Proapoptotic Molecule BLID Interacts with Bcl-X_L and Its Downregulation in Breast Cancer Correlates with Poor Disease-Free and Overall Survival

Constantinos G. Broustas, Jeffrey S. Ross, Qifeng Yang, Christine E. Sheehan, Rebecca Riggins, Anne-Michelle Noone, Bassem R. Haddad, Françoise Seillier-Moiseiwitsch, Bhaskar V.S. Kallakury, Bruce G. Haffty, Robert Clarke and Usha N. Kasid

Clin Cancer Res June 1 2010 16 (11) 2939-2948; DOI:10.1158/1078-0432.CCR-09-2351
Human Cancer Biology

The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma

Lili Li, Qian Tao, Hongchuan Jin, Andrew van Hasselt, Fan Fong Poon, Xian Wang, Mu-Sheng Zeng, Wei-Hua Jia, Yi-Xin Zeng, Anthony T.C. Chan and Ya Cao

Clin Cancer Res June 1 2010 16 (11) 2949-2958; DOI:10.1158/1078-0432.CCR-09-3178
Human Cancer Biology

The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes

Aurélie Docquier, Pierre-Olivier Harmand, Samuel Fritsch, Maïa Chanrion, Jean-Marie Darbon and Vincent Cavaillès

Clin Cancer Res June 1 2010 16 (11) 2959-2970; DOI:10.1158/1078-0432.CCR-09-3153
Human Cancer Biology

Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q− Neuroblastoma

Patrick G. Buckley, Leah Alcock, Kenneth Bryan, Isabella Bray, Johannes H. Schulte, Alexander Schramm, Angelika Eggert, Pieter Mestdagh, Katleen De Preter, Jo Vandesompele, Frank Speleman and Raymond L. Stallings

Clin Cancer Res June 1 2010 16 (11) 2971-2978; DOI:10.1158/1078-0432.CCR-09-3215
Human Cancer Biology

Telomere Maintenance and DNA Damage Responses during Lung Carcinogenesis

Sylvie Lantuejoul, Christophe Raynaud, Dimitri Salameire, Sylvie Gazzeri, Denis Moro-Sibilot, Jean-Charles Soria, Christian Brambilla and Elizabeth Brambilla

Clin Cancer Res June 1 2010 16 (11) 2979-2988; DOI:10.1158/1078-0432.CCR-10-0142

Cancer Therapy: Preclinical

Cancer Therapy: Preclinical | Free Article

Assessment of the In vivo Antitumor Effects of ENMD-2076, a Novel Multitargeted Kinase Inhibitor, against Primary and Cell Line–Derived Human Colorectal Cancer Xenograft Models

John J. Tentler, Erica L. Bradshaw-Pierce, Natalie J. Serkova, Kendra M. Hasebroock, Todd M. Pitts, Jennifer R. Diamond, Graham C. Fletcher, Mark R. Bray and S. Gail Eckhardt

Clin Cancer Res June 1 2010 16 (11) 2989-2998; DOI:10.1158/1078-0432.CCR-10-0325
Cancer Therapy: Preclinical

Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer

Gloria S. Huang, Jurriaan Brouwer-Visser, Marissa J. Ramirez, Christine H. Kim, Tiffany M. Hebert, Juan Lin, Hugo Arias-Pulido, Clifford R. Qualls, Eric R. Prossnitz, Gary L. Goldberg, Harriet O. Smith and Susan Band Horwitz

Clin Cancer Res June 1 2010 16 (11) 2999-3010; DOI:10.1158/1078-0432.CCR-09-3233

Imaging, Diagnosis, Prognosis

Imaging, Diagnosis, Prognosis

Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder Cancer

Tahlita C.M. Zuiverloon, Madelon N.M. van der Aa, Theo H. van der Kwast, Ewout W. Steyerberg, Hester F. Lingsma, Chris H. Bangma and Ellen C. Zwarthoff

Clin Cancer Res June 1 2010 16 (11) 3011-3018; DOI:10.1158/1078-0432.CCR-09-3013

Cancer Therapy: Clinical

Cancer Therapy: Clinical

A Phase I Study of 5-Fluorouracil/Leucovorin and Arsenic Trioxide for Patients with Refractory/Relapsed Colorectal Carcinoma

Bach Ardalan, Pochi R. Subbarayan, Yipsel Ramos, Michael Gonzalez, Anthony Fernandez, Dmitry Mezentsev, Isildinha Reis, Robert Duncan, Lisa Podolsky, Kelvin Lee, Mayra Lima and Parvin Ganjei-Azar

Clin Cancer Res June 1 2010 16 (11) 3019-3027; DOI:10.1158/1078-0432.CCR-09-2590
Cancer Therapy: Clinical

Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer

Tanya B. Dorff, Bryan Goldman, Jacek K. Pinski, Philip C. Mack, Primo N. Lara Jr., Peter J. Van Veldhuizen Jr., David I. Quinn, Nicholas J. Vogelzang, Ian M. Thompson Jr. and Maha H.A. Hussain

Clin Cancer Res June 1 2010 16 (11) 3028-3034; DOI:10.1158/1078-0432.CCR-09-3122
Cancer Therapy: Clinical

Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors

Petri Nokisalmi, Sari Pesonen, Sophie Escutenaire, Merja Särkioja, Mari Raki, Vincenzo Cerullo, Leena Laasonen, Ramon Alemany, Juan Rojas, Manel Cascallo, Kilian Guse, Maria Rajecki, Lotta Kangasniemi, Elina Haavisto, Aila Karioja-Kallio, Päivi Hannuksela, Minna Oksanen, Anna Kanerva, Timo Joensuu, Laura Ahtiainen and Akseli Hemminki

Clin Cancer Res June 1 2010 16 (11) 3035-3043; DOI:10.1158/1078-0432.CCR-09-3167
Cancer Therapy: Clinical

Phase 1 Study of AMG 386, a Selective Angiopoietin 1/2–Neutralizing Peptibody, in Combination with Chemotherapy in Adults with Advanced Solid Tumors

Alain C. Mita, Chris H. Takimoto, Monica Mita, Anthony Tolcher, Kamalesh Sankhala, John Sarantopoulos, Manuel Valdivieso, Leslie Wood, Erik Rasmussen, Yu-Nien Sun, Z. Don Zhong, Michael B. Bass, NgocDiep Le and Patricia LoRusso

Clin Cancer Res June 1 2010 16 (11) 3044-3056; DOI:10.1158/1078-0432.CCR-09-3368
Cancer Therapy: Clinical

A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer

Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia A. Creel, Kelly Mundy, S. Lindsay Davis, Ting Wang, Roula Albadine, Luciana Schultz, Alan W. Partin, Antonio Jimeno, Helen Fedor, Phillip G. Febbo, Daniel J. George, Robin Gurganus, Angelo M. De Marzo and Michael A. Carducci

Clin Cancer Res June 1 2010 16 (11) 3057-3066; DOI:10.1158/1078-0432.CCR-10-0124
Cancer Therapy: Clinical

Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

Kevin J. Harrington, Eleni M. Karapanagiotou, Victoria Roulstone, Katie R. Twigger, Christine L. White, Laura Vidal, Debbie Beirne, Robin Prestwich, Kate Newbold, Merina Ahmed, Khin Thway, Christopher M. Nutting, Matt Coffey, Dean Harris, Richard G. Vile, Hardev S. Pandha, Johann S. DeBono and Alan A. Melcher

Clin Cancer Res June 1 2010 16 (11) 3067-3077; DOI:10.1158/1078-0432.CCR-10-0054
Cancer Therapy: Clinical

A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naïve Patients with Advanced Non–Small Cell Lung Cancer

Joline S.W. Lind, Anne-Marie C. Dingemans, Harry J.M. Groen, Frederik B. Thunnissen, Otto Bekers, Daniëlle A.M. Heideman, Richard J. Honeywell, Elisa Giovannetti, Godefridus J. Peters, Pieter E. Postmus, Robert Jan van Suylen and Egbert F. Smit

Clin Cancer Res June 1 2010 16 (11) 3078-3087; DOI:10.1158/1078-0432.CCR-09-3033

Main menu

User menu

Search

Table of Contents

Highlights

CCR New Strategies

Molecular Pathways

Human Cancer Biology

Cancer Therapy: Preclinical

Imaging, Diagnosis, Prognosis

Cancer Therapy: Clinical

Issue Highlights

Jump to

Articles

Info for

About Clinical Cancer Research